RESEARCH HIGHLIGHT
To address the limited number of treatment options for children and young adults with glomerular diseases, the BRIDGE program at Riley Children’s Health integrates clinic visits and research, embedding longitudinal patient care with biorepository and registry development. The program improves access to expert care, facilitates crucial biomarker discovery and enhances recruitment for pediatric clinical trials.
>
READ about this novel program driving biomarker discovery and therapies for glomerular diseases.
TRAILBLAZERS
“Capitalizing on Riley’s large patient population and with virtually no barriers to participation, BRIDGE allows us to collect real-world longitudinal data that is representative of patients in our communities suffering from this condition. At Riley, we have both the resources and incredible patients who are willing to help; it just made sense to build a program that can help accelerate the pace of discovery.”
Myda Khalid, MD Associate Vice Chair of Clinical Trials, Riley Children’s Health Clinical Research Program Director, Pediatric Nephrology, Riley Children’s Health Professor of Clinical Pediatrics, IU School of Medicine > Connect with Dr. Khalid on Doximity.
Riley Children’s is nationally recognized for research in pediatric nephrology and a leading site for clinical trials aimed at discovering new treatments for children impacted by kidney disease. > Learn more about our program.
NEPHROLOGY AT RILEY CHILDREN’S
Made with FlippingBook flipbook maker